Fourth Circuit Breathes New Life into Monopolization Suit

Published date22 April 2021
Subject MatterPatents,Statute of Limitations,Appeals,Sherman Act,Manufacturers,Monopolization,The Clayton Act,Generic Drugs,Anti-Competitive,Antitrust Litigation,Drug Pricing,Pharmaceutical Industry
AuthorLisa Rumin,Marisa Poncia
Law FirmMcDermott Will & Emery

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT